Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Gerlinger

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Statistics in Medicine|July 6, 2007
Sperm count as a surrogate endpoint for male fertility controlNorbert Benda, Christoph Gerlinger
Pharmaceutical Statistics|September 21, 2011
Determining the non-inferiority margin for patient reported outcomesChristoph Gerlinger, Thomas Schmelter
Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives|February 2, 2018
Letter to the editor in response to "Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis" by Wickström and EdelstamChristoph Gerlinger, Jan Endrikat, Christian Seitz
BMJ Open|July 21, 2023
Substituting a randomised placebo control group with a historical placebo control in an endometriosis pain trial: a case study re-evaluating trial data using historical control data from another trialMarius Sieverding, Christoph Gerlinger, Christian Seitz
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 7, 2012
A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimenJoachim Marr, Christoph Gerlinger, Michael Kunz
Acta Obstetricia Et Gynecologica Scandinavica|April 28, 2007
Denial of pregnancy--characteristics of women at riskJens Wessel, Annett Gauruder-Burmester, Christoph Gerlinger
Drugs - Real World Outcomes|June 14, 2020
Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product ProfileChristoph Gerlinger, Thomas Evers, Jeremy Rassen, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 7, 2010
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled studyThomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, et al.
BMC Women'S Health|July 18, 2009
Pattern recognition in menstrual bleeding diaries by statistical cluster analysisChristoph Gerlinger, Jens Wessel, Gerd Kallischnigg, et al.
Biometrical Journal. Biometrische Zeitschrift|January 24, 2007
On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of themJoachim Röhmel, Christoph Gerlinger, Norbert Benda, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Statistics in Medicine|July 6, 2007
Sperm count as a surrogate endpoint for male fertility controlNorbert Benda, Christoph Gerlinger
Pharmaceutical Statistics|September 21, 2011
Determining the non-inferiority margin for patient reported outcomesChristoph Gerlinger, Thomas Schmelter
Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives|February 2, 2018
Letter to the editor in response to "Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis" by Wickström and EdelstamChristoph Gerlinger, Jan Endrikat, Christian Seitz
BMJ Open|July 21, 2023
Substituting a randomised placebo control group with a historical placebo control in an endometriosis pain trial: a case study re-evaluating trial data using historical control data from another trialMarius Sieverding, Christoph Gerlinger, Christian Seitz
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 7, 2012
A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimenJoachim Marr, Christoph Gerlinger, Michael Kunz
Acta Obstetricia Et Gynecologica Scandinavica|April 28, 2007
Denial of pregnancy--characteristics of women at riskJens Wessel, Annett Gauruder-Burmester, Christoph Gerlinger
Drugs - Real World Outcomes|June 14, 2020
Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product ProfileChristoph Gerlinger, Thomas Evers, Jeremy Rassen, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 7, 2010
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled studyThomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, et al.
BMC Women'S Health|July 18, 2009
Pattern recognition in menstrual bleeding diaries by statistical cluster analysisChristoph Gerlinger, Jens Wessel, Gerd Kallischnigg, et al.
Biometrical Journal. Biometrische Zeitschrift|January 24, 2007
On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of themJoachim Röhmel, Christoph Gerlinger, Norbert Benda, et al.
Pageof 9